Skip to main content
Premium Trial:

Request an Annual Quote

Lumera Signs Up ISB to Develop Label-Free Protein Array System

NEW YORK, Feb. 14 (GenomeWeb News) - Lumera will collaborate with the Institute for Systems Biology to develop a label-free protein microarray platform, the Bothell, Wash.-based company said today.

 

The platform will include Lumera's NanoCapture microarrays and its ProteomicProcessor reader, which does not require molecular labels. The new system will enable researchers to perform real-time kinetic measurements of protein-protein, protein-drug, and protein-DNA interactions.

 

Lumera plans to bring the technology to market "as quickly as possible," according to a company statement.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.